Sector revisions DexCom, Inc.

Stocks

Market Closed - Nasdaq 23:00:00 25/09/2026 +03			5-day change	1st Jan Change
86.62 ^USD	-0.97%		-3.06%	+30.51%

09-17	Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating	MT
09-16	Dexcom Insider Sold Shares Worth $679,769, According to a Recent SEC Filing	MT

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	DEXCOM, INC.							25
	ABBOTT LABORATORIES							25
	MEDTRONIC PLC							24
	CENCORA, INC.							12
	BECTON, DICKINSON AND COMPANY							12
	HOYA CORPORATION							15
	MEDLINE INC.							26
	WEST PHARMACEUTICAL SERVICES, INC.							16
	SARTORIUS STEDIM BIOTECH							14
	TERUMO CORPORATION							13
	STERIS PLC							8
	ZIMMER BIOMET HOLDINGS, INC.							21
	SOLVENTUM CORPORATION							13
	FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED							11
	BAXTER INTERNATIONAL INC.							11
	REPLIGEN CORPORATION							21
	AVANTOR, INC.							15
	ALIGN TECHNOLOGY, INC.							14
	BIO-RAD LABORATORIES, INC.							4
	GLOBUS MEDICAL, INC.							13
	Average							16
	Weighted average by Cap.							19